Share on StockTwits

Cardinal Health (NYSE:CAH) CFO Jeffrey William Henderson sold 118,093 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $69.72, for a total transaction of $8,233,443.96. Following the sale, the chief financial officer now directly owns 73,004 shares of the company’s stock, valued at approximately $5,089,839. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Cardinal Health (NYSE:CAH) traded up 0.42% during mid-day trading on Monday, hitting $71.24. 1,526,235 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $70.6 and a 200-day moving average of $69.35. The company has a market cap of $24.150 billion and a price-to-earnings ratio of 20.99.

Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.93%. The ex-dividend date is Monday, September 29th.

A number of research firms have recently commented on CAH. Analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Separately, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $74.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Cardinal Health has a consensus rating of “Buy” and a consensus target price of $78.03.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.